首页>投融资
Cellares
C轮
Cellares creating the future of cell therapy manufacturing and accelerating access to life-saving cell therapies.In Jan 2021, Cellares Corporation announced that PACT Pharma has joined Partnership Program.(2389781)In May 2021, Cellares Corporation announced it has secured $82 million in a Series B round
基本信息
-
公司全称Cellares Corp
-
类型细胞疗法制造解决方案及软件研发商
-
产业领域器械/设备、器械合同服务
-
公司人数15~50人
-
地址345 Allerton Ave SAN FRANCISCO CALIFORNIA 94080; US; Telephone: +18332355273;
-
联系电话833-235-5273
-
邮箱bd@cellares.com
-
成立时间2019-01-01
投融资
-
2023-08-23C轮2.55亿美元KDTEclipse Ventures8VC百时美施贵宝德诚资本Willett Advisors LLCDFJ Growth
-
2021-05-05B轮8200万美元8VCEclipse Ventures德诚资本
相关投融资企业
收并购
Dynamic Biosensors开发和销售用于研究复杂分子相互作用和动力学的创新技术，支持制药和生物技术行业以及基础和医学研究的药物发现。
C轮
Cellares creating the future of cell therapy manufacturing and accelerating access to life-saving cell therapies.In Jan 2021, Cellares Corporation announced that PACT Pharma has joined Partnership Program.(2389781)In May 2021, Cellares Corporation announced it has secured $82 million in a Series B round
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息